YZYujuan Zhou

Yujuan Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yujuan Zhou has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Chengzhi Xu

    ENT Institute and Department of Otorhinolaryngology Eye & ENT Hospital, Fudan University Xuhui District Shanghai China

    1 shared publication
  • Chunping Wu

    ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China

    1 shared publication
  • Hui Chen

    ENT Institute and Department of Otorhinolaryngology Eye & ENT Hospital, Fudan University Xuhui District Shanghai China

    1 shared publication
  • Lei Tao

    Department of Otorhinolaryngology Eye & ENT Hospital, Fudan University Shanghai China

    1 shared publication
  • Liang Zhou

    Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Qiang Huang

    ENT Institute and Department of Otorhinolaryngology Eye & ENT Hospital, Fudan University Xuhui District Shanghai China

    1 shared publication

Latest Publications

  • Open Access

    Circular RNAs in cancer

    by Yang Guo, Qiang Huang, Yu Heng, Yujuan Zhou, Hui Chen, Chengzhi Xu, Chunping Wu, Lei Tao, Liang Zhou

    Circular RNA (circRNA), a subtype of noncoding RNA, has emerged as a significant focus in RNA research due to its distinctive covalently closed loop structure. CircRNAs play pivotal roles in diverse physiological and pathological processes, functioning through mechanisms such as miRNAs or proteins sponging, regulation of splicing and gene expression, and serving as translation templates, particularly in the context of various cancers. The hallmarks of cancer comprise functional capabilities acquired during carcinogenesis and tumor progression, providing a conceptual framework that elucidates the nature of the malignant transformation. Although numerous studies have elucidated the role of circRNAs in the hallmarks of cancers, their functions in the development of chemoradiotherapy resistance remain unexplored and the clinical applications of circRNA‐based translational therapeutics are still in their infancy. This review provides a comprehensive overview of circRNAs, covering their biogenesis, unique characteristics, functions, and turnover mechanisms. We also summarize the involvement of circRNAs in cancer hallmarks and their clinical relevance as biomarkers and therapeutic targets, especially in thyroid cancer (TC). Considering the potential of circRNAs as biomarkers and the fascination of circRNA‐based therapeutics, the “Ying‐Yang” dynamic regulations of circRNAs in TC warrant vastly dedicated investigations.